NSEUpdatesM&A1 Sept 2026
India Glycols Limited
Updates
India Glycols Limited has informed the Exchange regarding 'Effectiveness of the Scheme of Arrangement' for demerging into three separate entities: India Glycols Limited, IGL Spirits Limited, and Ennature Bio Pharma Limited. The demerger is effective September 1, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates28 Aug 2026
India Glycols Limited
Analysts/Institutional Investor Meet/Con. Call Updates
India Glycols Limited has informed the Exchange about the schedule of an Analyst/Institutional Investor Meeting, which will be held on September 2nd, 2026, in Mumbai.
NSEUpdatesMgmt Change21 Aug 2026
India Glycols Limited
Updates
India Glycols Limited has informed the Exchange regarding 'Material Update in Connection with IGL Spirits Limited with reference to Observation Letters issued by the National Stock Exchange of India Limited and BSE Limited. The company has approved the appointment of new directors and key managerial personnel.
NSEUpdates21 Aug 2026
India Glycols Limited
Updates
NSERecord DateM&A21 Aug 2026
India Glycols Limited
Record Date
India Glycols Limited has informed the Exchange that the Record Date for the purpose of Merger/HiveOff is 02-Sep-2026, as part of a Scheme of Arrangement amongst the company, Ennature Bio Pharma Limited, and IGL Spirits Limited.
NSEGeneral UpdatesM&A21 Aug 2026
India Glycols Limited
General Updates
India Glycols Limited has informed the Exchange about General Updates, specifically the fixation of Effective Date and Record Date for Allotment of Shares pursuant to Scheme of Arrangement.
NSECopy of Newspaper PublicationResults21 Aug 2026
India Glycols Limited
Copy of Newspaper Publication
India Glycols Limited has informed the Exchange about the submission of a newspaper advertisement regarding a special window for transfer and dematerialization of physical shares.
NSEUpdatesM&A20 Aug 2026
India Glycols Limited
Updates
India Glycols Limited has received a certified true copy of the order of the National Company Law Tribunal (NCLT) dated 17th July, 2026, approving the Scheme of Arrangement amongst India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults20 Aug 2026
India Glycols Limited
Analysts/Institutional Investor Meet/Con. Call Updates
India Glycols Limited has informed the Exchange about the transcript of the Q1FY27 Earnings Conference Call, which was hosted by InCred Equities. The company's management, including CEO Rupark Sarswat, CFO Anand Singhal, and others, presented the results and answered questions from investors.
NSEShareholders meeting19 Aug 2026
India Glycols Limited
Shareholders meeting
India Glycols Limited has informed the Exchange about the outcome of the 42nd Annual General Meeting, including the voting results and consolidated scrutinizer's report.
NSEUpdates19 Aug 2026
India Glycols Limited
Updates
India Glycols Limited has responded to a BSE query regarding increased volume movement, stating that there is no undisclosed information or event that needs to be disclosed, and attributing the increase to market-driven factors.
NSESpurt in VolumeRegulatory19 Aug 2026
India Glycols Limited
Spurt in Volume
India Glycols Limited has responded to the NSE's query regarding the sudden increase in volume, stating that there is no undisclosed information or event that needs to be disclosed under SEBI Listing Regulations. The company attributes the increase to market-driven factors and reaffirms its commitment to keeping the stock exchanges informed of all necessary information.
NSESpurt in VolumeRegulatory18 Aug 2026
India Glycols Limited
Spurt in Volume
India Glycols Limited has observed a significant increase in volume, prompting the exchange to write to the company to ensure investors have the latest information and to safeguard their interest.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults14 Aug 2026
India Glycols Limited
Analysts/Institutional Investor Meet/Con. Call Updates
India Glycols Limited has made the audio recording of its Q1FY27 earnings conference call available on its website.
NSEInvestor Presentation▲ PositiveResults14 Aug 2026
India Glycols Limited
Investor Presentation
India Glycols Limited has announced its Q1FY27 financial results, with a robust performance driven by a diversified portfolio and focused execution. The company has reported double-digit growth in Gross Revenue, EBITDA, and PAT. The proposed restructuring has received NCLT approval, with implementation activities progressing.
NSEUpdates13 Aug 2026
India Glycols Limited
Updates
India Glycols Limited has issued a reminder to its physical shareholders to furnish their PAN, KYC details, and nomination, as mandated by SEBI. Shareholders who have not updated their details will be eligible for certain services only after furnishing the required documents.
NSEUpdatesMgmt Change12 Aug 2026
India Glycols Limited
Updates
India Glycols Limited has informed the Exchange regarding 'Outcome of the Board Meeting' where the Board of Directors has re-designated Ms. Pragya Bhartia Barwale from Whole Time Director and Key Managerial Person to Non-Executive Non-Independent Director of the Company.
NSEChange in Director(s)Mgmt Change12 Aug 2026
India Glycols Limited
Change in Director(s)
India Glycols Limited has informed the Exchange regarding Change in Director(s) of the company, specifically the re-designation of Ms. Pragya Bhartia Barwale from Whole Time Director and Key Managerial Person to Non-Executive Non-Independent Director.
NSEOutcome of Board Meeting▲ PositiveResults12 Aug 2026
India Glycols Limited
Outcome of Board Meeting
India Glycols Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 96.83 crore.
NSEGeneral UpdatesResults6 Aug 2026
India Glycols Limited
General Updates
India Glycols Limited has informed the Exchange about General Updates, specifically the intimation of Q1FY27 Earnings Conference Call to be held on 14th August, 2026.